Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-22-024752
Filing Date
2022-07-01
Accepted
2022-07-01 16:23:05
Documents
1
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3226
  Complete submission text file 0000899243-22-024752.txt   4612
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VENTYX BIOSCIENCES, INC. 332 ENCINITAS BLVD. SUITE 200 ENCINITAS CA 92024
Business Address
Choksey Jigar (Reporting) CIK: 0001873762 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40928 | Film No.: 221061734